NEW YORK (Reuters) – Preliminary findings from two vaccine safety monitoring systems suggest a higher-than-expected number of cases of heart inflammation after the second dose of mRNA COVID-19 vaccines in 16 to 24 year olds, the U.S. Centers for Disease Control and Prevention said on Thursday.
The limited data shows that most of the patients – at least 81 percent of them – had a full recovery from their symptoms, the CDC said in a presentation https://www.fda.gov/media/150054/download prepared for an advisory committee to the U.S. Food and Drug Administration that is meeting on Thursday.
(Reporting by Michael Erman)
